According to this study, Global Oral Solid Dosage Pharmaceutical Formulation market size will reach US$ million by 2031.

Global Oral Solid Dosage Pharmaceutical Formulation Market Trends and Opportunities 2025-31

According to this study, the global Oral Solid Dosage Pharmaceutical Formulation market size will reach US$ million by 2031. Oral solid dosage forms are the most commonly used pharmaceuticals to treat various disease conditions. Oral solid dosage forms are cost-effective and easy to manufacture in comparison with other dosage forms. They offer significant benefits to manufacturers such as trouble free packaging and transportation and increased chemical and physical stability. Oral solids offer many advantages to patients as well. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. LPI (LP Information) newest research report, the Oral Solid Dosage Pharmaceutical Formulation Industry Forecast looks at past sales and reviews total world Oral Solid Dosage Pharmaceutical Formulation sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Solid Dosage Pharmaceutical Formulation sales for 2025 through 2031. With Oral Solid Dosage Pharmaceutical Formulation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Solid Dosage Pharmaceutical Formulation industry. This Insight Report provides a comprehensive analysis of the global Oral Solid Dosage Pharmaceutical Formulation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral Solid Dosage Pharmaceutical Formulation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Oral Solid Dosage Pharmaceutical Formulation market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Solid Dosage Pharmaceutical Formulation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Solid Dosage Pharmaceutical Formulation. This report presents a comprehensive overview, market shares, and growth opportunities of Oral Solid Dosage Pharmaceutical Formulation market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Immediate Release &nbsp;&nbsp;&nbsp; Extended Release &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital Pharmacy &nbsp;&nbsp;&nbsp; Retail Pharmacy &nbsp;&nbsp;&nbsp; Drug Stores &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; AstraZeneca &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb &nbsp;&nbsp;&nbsp; Eli Lilly &nbsp;&nbsp;&nbsp; Gilead &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; AbbVie &nbsp;&nbsp;&nbsp; Boehringer Ingelheim

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size (2020-2031) &nbsp;2.1.2 Oral Solid Dosage Pharmaceutical Formulation Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Oral Solid Dosage Pharmaceutical Formulation by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Oral Solid Dosage Pharmaceutical Formulation Segment by Type &nbsp;2.2.1 Immediate Release &nbsp;2.2.2 Extended Release &nbsp;2.2.3 Others &nbsp;2.3 Oral Solid Dosage Pharmaceutical Formulation Market Size by Type &nbsp;2.3.1 Oral Solid Dosage Pharmaceutical Formulation Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Market Share by Type (2020-2025) &nbsp;2.4 Oral Solid Dosage Pharmaceutical Formulation Segment by Application &nbsp;2.4.1 Hospital Pharmacy &nbsp;2.4.2 Retail Pharmacy &nbsp;2.4.3 Drug Stores &nbsp;2.4.4 Others &nbsp;2.5 Oral Solid Dosage Pharmaceutical Formulation Market Size by Application &nbsp;2.5.1 Oral Solid Dosage Pharmaceutical Formulation Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Market Share by Application (2020-2025) 3 Oral Solid Dosage Pharmaceutical Formulation Market Size by Player &nbsp;3.1 Oral Solid Dosage Pharmaceutical Formulation Market Size Market Share by Player &nbsp;3.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Player (2020-2025) &nbsp;3.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Oral Solid Dosage Pharmaceutical Formulation Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Oral Solid Dosage Pharmaceutical Formulation by Region &nbsp;4.1 Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2020-2025) &nbsp;4.2 Global Oral Solid Dosage Pharmaceutical Formulation Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Oral Solid Dosage Pharmaceutical Formulation Market Size Growth (2020-2025) &nbsp;4.4 APAC Oral Solid Dosage Pharmaceutical Formulation Market Size Growth (2020-2025) &nbsp;4.5 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2020-2025) &nbsp;5.2 Americas Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2020-2025) &nbsp;5.3 Americas Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2020-2025) &nbsp;6.2 APAC Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2020-2025) &nbsp;6.3 APAC Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2020-2025) &nbsp;7.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2020-2025) &nbsp;7.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation by Region (2020-2025) &nbsp;8.2 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Oral Solid Dosage Pharmaceutical Formulation Market Forecast &nbsp;10.1 Global Oral Solid Dosage Pharmaceutical Formulation Forecast by Region (2026-2031) &nbsp;10.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.1.3 APAC Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.1.4 Europe Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.1.5 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.2 Americas Oral Solid Dosage Pharmaceutical Formulation Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.2.2 Canada Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.2.3 Mexico Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.2.4 Brazil Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.3 APAC Oral Solid Dosage Pharmaceutical Formulation Forecast by Region (2026-2031) &nbsp;10.3.1 China Oral Solid Dosage Pharmaceutical Formulation Market Forecast &nbsp;10.3.2 Japan Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.3.3 Korea Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.3.4 Southeast Asia Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.3.5 India Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.3.6 Australia Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.4 Europe Oral Solid Dosage Pharmaceutical Formulation Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.4.2 France Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.4.3 UK Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.4.4 Italy Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.4.5 Russia Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.5 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.5.2 South Africa Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.5.3 Israel Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.5.4 Turkey Market Oral Solid Dosage Pharmaceutical Formulation Forecast &nbsp;10.6 Global Oral Solid Dosage Pharmaceutical Formulation Forecast by Type (2026-2031) &nbsp;10.7 Global Oral Solid Dosage Pharmaceutical Formulation Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Oral Solid Dosage Pharmaceutical Formulation Forecast 11 Key Players Analysis &nbsp;11.1 AstraZeneca &nbsp;11.1.1 AstraZeneca Company Information &nbsp;11.1.2 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Product Offered &nbsp;11.1.3 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 AstraZeneca Main Business Overview &nbsp;11.1.5 AstraZeneca Latest Developments &nbsp;11.2 Bristol-Myers Squibb &nbsp;11.2.1 Bristol-Myers Squibb Company Information &nbsp;11.2.2 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Product Offered &nbsp;11.2.3 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Bristol-Myers Squibb Main Business Overview &nbsp;11.2.5 Bristol-Myers Squibb Latest Developments &nbsp;11.3 Eli Lilly &nbsp;11.3.1 Eli Lilly Company Information &nbsp;11.3.2 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Product Offered &nbsp;11.3.3 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Eli Lilly Main Business Overview &nbsp;11.3.5 Eli Lilly Latest Developments &nbsp;11.4 Gilead &nbsp;11.4.1 Gilead Company Information &nbsp;11.4.2 Gilead Oral Solid Dosage Pharmaceutical Formulation Product Offered &nbsp;11.4.3 Gilead Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Gilead Main Business Overview &nbsp;11.4.5 Gilead Latest Developments &nbsp;11.5 Merck &nbsp;11.5.1 Merck Company Information &nbsp;11.5.2 Merck Oral Solid Dosage Pharmaceutical Formulation Product Offered &nbsp;11.5.3 Merck Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Merck Main Business Overview &nbsp;11.5.5 Merck Latest Developments &nbsp;11.6 Novartis &nbsp;11.6.1 Novartis Company Information &nbsp;11.6.2 Novartis Oral Solid Dosage Pharmaceutical Formulation Product Offered &nbsp;11.6.3 Novartis Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Novartis Main Business Overview &nbsp;11.6.5 Novartis Latest Developments &nbsp;11.7 Pfizer &nbsp;11.7.1 Pfizer Company Information &nbsp;11.7.2 Pfizer Oral Solid Dosage Pharmaceutical Formulation Product Offered &nbsp;11.7.3 Pfizer Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Pfizer Main Business Overview &nbsp;11.7.5 Pfizer Latest Developments &nbsp;11.8 AbbVie &nbsp;11.8.1 AbbVie Company Information &nbsp;11.8.2 AbbVie Oral Solid Dosage Pharmaceutical Formulation Product Offered &nbsp;11.8.3 AbbVie Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 AbbVie Main Business Overview &nbsp;11.8.5 AbbVie Latest Developments &nbsp;11.9 Boehringer Ingelheim &nbsp;11.9.1 Boehringer Ingelheim Company Information &nbsp;11.9.2 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Product Offered &nbsp;11.9.3 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Boehringer Ingelheim Main Business Overview &nbsp;11.9.5 Boehringer Ingelheim Latest Developments 12 Research Findings and Conclusion

Report	Global Oral Solid Dosage Pharmaceutical Formulation Market Growth (Status and Outlook) 2025-2031
Selected License	Single ID:LPI21617

Buyer Information

Order Summary